Filipa Santos

Filipa Santos

Auto-generated profile, based on publicly available information

Filipa Santos

Pathology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2018 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
FSFilipa Santos
Filipa Santos
CMCarmo Martins
Carmo Martins
MLMaria M. Lemos
Maria M. Lemos

1 October 2025 in Cancer Research Communications
Verified
Journal Article
Open access
MEMiguel Esperança-Martins
Miguel Esperança-Martins
HVHugo Vasques
Hugo Vasques
MRManuel Sérgio Sokolov Ravasqueira
Manuel Sérgio Sokolov Ravasqueira
FSFilipa Santos
Filipa Santos
FFFilipa Fonseca
Filipa Fonseca
Sérgio DiasSérgio Dias
Sérgio Dias
Undifferentiated pleomorphic sarcoma (UPS) remains one of the most clinically aggressive and poorly characterized soft-tissue sarcoma subtypes. To uncover distinctive molecular traits for UPS, a multiomics analysis of UPS compared with leiomyosarcoma (LMS) and liposarcoma (LPS) was performed. Transcriptomic profiling revealed that UPS exhibits overexpression of genes encoding succinate dehydrogenase (SDH) subunits, particularly SDHB, SDHC, and SDHD, distinguishing it from LMS and dedifferentiated LPS. This finding was validated using The Cancer Genome Atlas Sarcoma dataset. High SDHB expression in UPS was significantly associated with shorter overall survival, shorter recurrence-free survival, and shorter overall survival from the date of first metastasis. IHC validated elevated SDHB protein levels in UPS and LMS relative to dedifferentiated LPS. Despite overexpression of SDH subunits, metabolomic profiling demonstrated a significantly higher succinate-to-fumarate ratio in UPS, suggesting functional impairment of SDH enzymatic activity potentially due to posttranslational modifications, altered assembly of SDH subunits, or imbalanced tricarboxylic acid flux. This paradoxical phenotype of SDH overexpression with enzymatic dysfunction defines a unique molecular and metabolic subtype of UPS with prognostic significance. Recognition of this distinct SDH-associated molecular and metabolic phenotype provides insights into UPS pathogenesis, identifies a potential novel prognostic biomarker, and suggests a new avenue for metabolic-targeted therapy. Significance: This study identified a paradoxical phenotype of SDH subunit overexpression with functional impairment in UPS, defining a molecular/metabolic subtype associated with poor prognosis. It offers new data on UPS pathogenesis and treatment.

Verified
Journal Article
Open access
PDF file
IPInês Peyroteo
Inês Peyroteo
FSFilipa Santos
Filipa Santos
CMCelso Marialva
Celso Marialva
RRRodrigo Brito Ramos
Rodrigo Brito Ramos
Purpose: Our objective was to investigate the association between programmed death-ligand (PD-L1) immunoexpression measured as a combined positive score and clinical outcomes in penile SqCC. Materials and methods: We retrospectively reviewed all penile SqCC cases diagnosed in our institution between 2018 and 2023. PD-L1 immunohistochemistry was performed as a qualitative assay. Immunoexpression in both tumor and immune cells equal or superior to 1 was considered positive.Results: A total of 34 patients with conventional penile SqCC were included. Eleven cases were HPV-associated (32.4%). Twelve cases were PD-L1 CPS < 1 and twenty-two were PD-L1 CPS ≥ 1. Nine cases (32.4%) were PD-L1 CPS ≥ 1 and p16 positive, but this did not translate in worse clinicopathological features. Larger tumors (3.0 cm in PD-L1 CPS ≥ 1 vs 2.5 cm in PD-L1 CPS < 1; p = 0.662), vascular invasion (36.4% in PD-L1 CPS ≥ 1 vs. 25.0% in PD-L1 CPS < 1; p = 0.705) and perineural invasion (40.9% in PD-L1 CPS≥1 vs. 16.7% in PD-L1 CPS < 1; p = 0.252) were associated with PD-L1 expression. Among the high-risk features, only lymph node involvement had statistical significance, with 14 out of 22 PD-L1 CPS ≥ 1 patients (63.6%) having lymph node metastases when lymphadenectomy was performed (p = 0.031). With a median follow-up of 16 months (IQR 27.5), PD-L1 CPS ≥ 1 patients had worse overall survival (53.4 months vs 75.9 months), but no statistical significance could be inferred (p = 0.188).Conclusions: It is noteworthy the clinical significance of lymph node involvement in PD-L1 CPS ≥ 1 cases and a trend towards worse overall survival in this group of patients.

30 October 2025
Verified
Other
Open access
MEMiguel Esperança-Martins
Miguel Esperança-Martins
HVHugo Vasques
Hugo Vasques
MRManuel Sérgio Sokolov Ravasqueira
Manuel Sérgio Sokolov Ravasqueira
FSFilipa Santos
Filipa Santos
FFFilipa Fonseca
Filipa Fonseca
Sérgio DiasSérgio Dias
Sérgio Dias
Supplementary Figure 25 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma


30 October 2025
Verified
Other
Open access
MEMiguel Esperança-Martins
Miguel Esperança-Martins
HVHugo Vasques
Hugo Vasques
MRManuel Sérgio Sokolov Ravasqueira
Manuel Sérgio Sokolov Ravasqueira
FSFilipa Santos
Filipa Santos
FFFilipa Fonseca
Filipa Fonseca
Sérgio DiasSérgio Dias
Sérgio Dias
Supplementary Figure 3 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma